187,449 Shares in Semler Scientific, Inc. (NASDAQ:SMLR) Acquired by Driehaus Capital Management LLC

Driehaus Capital Management LLC bought a new stake in Semler Scientific, Inc. (NASDAQ:SMLRFree Report) during the fourth quarter, Holdings Channel.com reports. The firm bought 187,449 shares of the company’s stock, valued at approximately $10,122,000.

Several other large investors have also modified their holdings of SMLR. Global Retirement Partners LLC boosted its stake in Semler Scientific by 62.5% during the fourth quarter. Global Retirement Partners LLC now owns 1,300 shares of the company’s stock worth $70,000 after buying an additional 500 shares during the period. Kovitz Investment Group Partners LLC boosted its position in shares of Semler Scientific by 2.2% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company’s stock worth $1,236,000 after purchasing an additional 501 shares during the period. NewEdge Advisors LLC raised its position in Semler Scientific by 318.3% in the fourth quarter. NewEdge Advisors LLC now owns 732 shares of the company’s stock valued at $40,000 after purchasing an additional 557 shares during the period. BNP Paribas Financial Markets purchased a new position in shares of Semler Scientific during the fourth quarter worth $30,000. Finally, Sanctuary Advisors LLC grew its stake in shares of Semler Scientific by 13.2% in the fourth quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company’s stock valued at $261,000 after buying an additional 584 shares in the last quarter. Institutional investors and hedge funds own 49.37% of the company’s stock.

Analyst Ratings Changes

Separately, Lake Street Capital raised their target price on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a report on Friday, January 24th.

Check Out Our Latest Report on Semler Scientific

Semler Scientific Stock Down 1.3 %

Shares of SMLR opened at $34.79 on Friday. The company has a market capitalization of $333.88 million, a price-to-earnings ratio of 7.09 and a beta of 1.33. Semler Scientific, Inc. has a 52-week low of $21.77 and a 52-week high of $81.56. The stock has a 50 day moving average price of $35.05 and a 200 day moving average price of $46.46.

Semler Scientific (NASDAQ:SMLRGet Free Report) last posted its earnings results on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The firm had revenue of $12.41 million for the quarter.

Semler Scientific Profile

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.

See Also

Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLRFree Report).

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.